Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$126.46 - $235.05 $169,962 - $315,907
-1,344 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$225.82 - $368.51 $8,355 - $13,634
37 Added 2.83%
1,344 $341,000
Q3 2021

Nov 08, 2021

BUY
$221.9 - $484.47 $68,123 - $148,732
307 Added 30.7%
1,307 $503,000
Q2 2021

Aug 10, 2021

BUY
$129.91 - $234.98 $129,910 - $234,980
1,000 New
1,000 $235,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Marcum Wealth, LLC Portfolio

Follow Marcum Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marcum Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marcum Wealth, LLC with notifications on news.